This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamin industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.
Here is the Editor's Note for you to know about the April issue specifically:
The China-US trade war has worried industry participants about a potential decline in vitamin exports. Some of the listed vitamin producers have responded accordingly. the report producer considers that the trade war will have a limited influence on China's vitamin exports. In the entire 2017, the U.S. imported USD4 billion worth of APIs from China, becoming China's second largest API export destination.
April has seen several new projects in the animal nutriment market. Changsha Dogain reached a partnership with a local industrial park to produce vitamin nutriment for animals, and the project is scheduled to be launched in Aug. 2019; Beijing Enhalor started the construction of the animal nutrients project, which will make it the biggest producer of stabilised VC in China. the report producer predicts that the global animal health-care industry will keep an annual growth rate of 20%, and as an important additive in animal nutriment, vitamins will also have a bright outlook.
Vitamin enterprises' financial performance improved in 2017. Bluestar Adisseo's gross profit margin in the vitamin business increased from 11% to 18% in 2017; Hebei Yuxing's net profit surged by 50.66% YoY, mainly thanks to its efforts in expanding the business into the corn deep-processing industry. Under the high environmental pressure, more enterprises are predicted to follow Hebei Yuxing and seek new sources of profit for reduced costs.
Vitamins China E-News is a monthly published newsletter, which can be downloaded in PDF format. The subscription mode for this newsletter is yearly and the subscriber will receive 12 issues per year.
MEP formulating VOCs treatment action plan
Column2 Market Dynamics
Listed vitamin enterprises see good financial results in 2017
CSPC Pharmaceutical the biggest API exporter in 2017
VK2 gaining popularity in China
Column 3 Company Developments
Update on Huisheng Pharmaceutical’s fire accident in last September
Chongqing Sansheng to build folic acid and VB5 in Jilin Province
Zhejiang NHU applies for invention award for VA palmitate enzymatic method production technique
Garden Biochemical to establish wholly-owned subsidiary
Column 4 Import and Export Analysis
Imports & exports of selected vitamins in China, Jan. 2018
China’s vitamin export volume decreases in January 2018
Column 5 Price Update
Ex-works prices of selected vitamins in China, March 2018
Jilin Beisha greatly raises VE quotations
Column 6 News in Brief
Zhejiang NHU predicts YoY increase in net profit in 2017
Kingdomway predicts YoY increase in net profit in 2017
Yifan Pharmaceutical predicts YoY increase in net profit in 2017
Brother Enterprises predicts YoY increase in net profit in 2017
Garden Biochemical predicts YoY surge in net profit in 2017
Guanfu predicts YoY surge in revenue in 2017
North China Pharmaceutical’s VC project to start construction in April
Update on North China Pharamaceutical’s Zhaoxian-based project
Jiangsu Brother Enterprises resumes production
Nenter raises feed grade VE quotation
- Changsha Dogain Biotechnology Co., Ltd.
- Fujian Haixin Pharmaceutical Co., Ltd.
- Beijing Enhalor International Tech Co., Ltd.
- Hebei Yuxing Bio-engineering Co., Ltd.
- Hainan Kang Nongtang Chinese Medicine Co. Ltd.